HSPD1-targeted anti-cancer effects dependent on oxidative phosphorylation. »
08/07/21

3Br-P + DCA treatment remarkably down-regulated the expression of Bcl-2. »
08/07/21

3Br-P + DCA treatment remarkably down-regulated the expression of Bcl-2. »
08/07/21

Low baseline HGF independently prognostic for improved PFS for both cabozantinib and everolimus. »
08/07/21

CD8 to FOXP3 ratio and CD4 to FOXP3 ratio associated with better OS. »
08/06/21

TRAIL-based therapy killed approximately 75% of single CTCs and CTC in cluster form. »
08/06/21

Xenograft studies demonstrated that tumor reduction potent with Ref-1 redox inhibitor. »
08/10/21

Suitability of breast cancer PDO as 3-dimensional model. »
08/10/21

Men and those aged 65–74 reported less symptoms than women and those aged 50–64 years. »
08/10/21

Patients who experienced a 30% or greater reduction in CC dimension had improved OS. »
08/09/21